Understanding Your Child's ITK Deficiency Diagnosis
At a Glance
ITK deficiency is a rare inherited immune disorder caused by changes in both copies of the ITK gene. It weakens T-cell responses, especially against EBV, so children need specialist monitoring for infections, abnormal immune-cell growth, and severe inflammation.
Receiving a diagnosis of ITK deficiency is a life-altering moment. It is natural to feel a profound sense of shock, fear, or even disbelief as you begin to navigate a world of complex medical terms and rare conditions. This page is designed to help you understand what is happening inside your child’s body and why this diagnosis occurred. It provides a foundation for the conversations you will have with your child’s immunology team.
Please note that this page focuses on the nature of the diagnosis itself. Information regarding emergency warning signs and everyday symptom monitoring is covered in the Symptoms section of this guide.
What is ITK Deficiency?
ITK deficiency is an extremely rare genetic disorder that affects the immune system. It belongs to a group of conditions known as primary immunodeficiencies, where a part of the body’s natural defense system is missing or does not function correctly [1][2].
In a healthy immune system, T-cells (a type of white blood cell) act like the “special forces” of the body. They identify and destroy cells infected with viruses. For a T-cell to do its job, it must receive clear communication signals through its T-cell receptor. The ITK gene provides the instructions for a protein that acts as a crucial “volume dial” for these signals [3][4].
In children with ITK deficiency, this protein is either missing or broken. Without it, the T-cells become impaired to certain threats. They may detect a virus but cannot mount a strong enough response to stop it [5][6].
The Role of the ITK Gene
The ITK gene is responsible for “tuning” the immune response. When a T-cell encounters a germ, the ITK protein helps translate that encounter into action—telling the cell to multiply, move to the site of infection, and release chemicals to kill the intruder [3][5].
Without functional ITK:
- Weak Communication: T-cells receive weak signals and may not multiply correctly when they are needed [7].
- Impaired “Killing” Ability: A specific group called CD8+ T-cells (cytotoxic T-cells) cannot properly release the chemicals needed to destroy infected cells [8][5].
- Increased Cell Death: The T-cells themselves may die off too easily (a process called apoptosis), leading to low counts of certain immune cells over time [7].
The Vulnerability to EBV
One of the most significant challenges in ITK deficiency is the body’s inability to control the Epstein-Barr Virus (EBV). EBV is a very common virus that can cause infectious mononucleosis (“mono”) and is carried by most people. In a healthy child, T-cells easily keep EBV in check for life [9].
In ITK deficiency, the T-cells cannot effectively clear the cells infected with EBV. This allows the virus to grow unchecked, which can lead to:
- EBV-positive Lymphoproliferative Disease: A condition where EBV-infected cells multiply out of control [10][11].
- Lymphoma: This uncontrolled growth can sometimes turn into cancer, such as Hodgkin or non-Hodgkin lymphoma [12][10].
- Hemophagocytic Lymphohistiocytosis (HLH): A severe, overactive immune response that causes life-threatening inflammation throughout the body [10][8].
Validating your fear when hearing these terms is important; these are serious risks that your medical team will monitor for closely.
How ITK Deficiency is Inherited
ITK deficiency is an autosomal recessive disorder. This means a child must inherit two copies of the mutated gene—one from each parent—to have the condition [1][13].
- Carriers: Usually, both parents are “carriers.” They have one healthy ITK gene and one mutated ITK gene. Carriers typically have no symptoms and no immune problems because their one healthy gene provides enough ITK protein for their system to function normally.
- The Odds: When two confirmed carriers have a child, there is a probability for each pregnancy of:
- 25% chance the child will have ITK deficiency (inherits two mutated genes).
- 50% chance the child will be a healthy carrier (inherits one mutated gene).
- 25% chance the child will not have the mutation at all (inherits two healthy genes).
It is important to understand that this is a random genetic event. Nothing you did, or did not do, caused this mutation to occur. A genetic counselor can help visually map this out (a pedigree) for family planning and sibling testing.
Navigating the Emotional Impact
Receiving a diagnosis of a severe immune disorder is often described by parents as a journey of “chronic uncertainty” [14]. It is normal to experience a wide range of emotions, including:
- Anxiety and Fear: Worrying about the future and the risks of infections or complications [15].
- Grief and Guilt: Mourning the “normal” childhood you envisioned or feeling responsible for the genetic inheritance, even though it was beyond your control [14].
- Overwhelm: Feeling buried under new medical information, appointments, and the pressure of making treatment decisions [16][17].
Many parents find it helpful to seek out peer support—connecting with other families who are managing rare genetic or immune conditions—to reduce the sense of isolation [17][16]. Your medical team is there not just to treat your child’s body, but to support your family through this transition.
Common questions in this guide
What is ITK deficiency, and how does it affect a child’s immune system?
How does a child inherit ITK deficiency?
Why is Epstein-Barr virus a particular concern for children with ITK deficiency?
What tests may doctors use to monitor a child with ITK deficiency?
Should parents meet with a genetic counselor after an ITK deficiency diagnosis?
How can families cope with an ITK deficiency diagnosis?
Get notified when new evidence is published on Combined immunodeficiency due to ITK deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesis.
Lechner KS, Neurath MF, Weigmann B
Journal of molecular medicine (Berlin, Germany) 2020; (98(10)):1385-1395 doi:10.1007/s00109-020-01958-z.
PMID: 32808093 - 2
Inherited Interleukin 2-Inducible T-Cell (ITK) Kinase Deficiency in Siblings With Epidermodysplasia Verruciformis and Hodgkin Lymphoma.
Youssefian L, Vahidnezhad H, Yousefi M, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019; (68(11)):1938-1941 doi:10.1093/cid/ciy942.
PMID: 30778533 - 3
Multidomain Control Over TEC Kinase Activation State Tunes the T Cell Response.
Andreotti AH, Joseph RE, Conley JM, et al.
Annual review of immunology 2018; (36()):549-578 doi:10.1146/annurev-immunol-042617-053344.
PMID: 29677469 - 4
Hierarchy of signaling thresholds downstream of the T cell receptor and the Tec kinase ITK.
Gallagher MP, Conley JM, Vangala P, et al.
Proceedings of the National Academy of Sciences of the United States of America 2021; (118(35)) doi:10.1073/pnas.2025825118.
PMID: 34452995 - 5
Magnesium Restores Activity to Peripheral Blood Cells in a Patient With Functionally Impaired Interleukin-2-Inducible T Cell Kinase.
Howe MK, Dowdell K, Roy A, et al.
Frontiers in immunology 2019; (10()):2000 doi:10.3389/fimmu.2019.02000.
PMID: 31507602 - 6
Itk signals promote neuroinflammation by regulating CD4+ T-cell activation and trafficking.
Kannan AK, Kim DG, August A, Bynoe MS
The Journal of neuroscience : the official journal of the Society for Neuroscience 2015; (35(1)):221-33 doi:10.1523/JNEUROSCI.1957-14.2015.
PMID: 25568116 - 7
Genetic Deficiency and Biochemical Inhibition of ITK Affect Human Th17, Treg, and Innate Lymphoid Cells.
Eken A, Cansever M, Somekh I, et al.
Journal of clinical immunology 2019; (39(4)):391-400 doi:10.1007/s10875-019-00632-5.
PMID: 31025232 - 8
Inducible T Cell Kinase Regulates the Acquisition of Cytolytic Capacity and Degranulation in CD8+ CTLs.
Kapnick SM, Stinchcombe JC, Griffiths GM, Schwartzberg PL
Journal of immunology (Baltimore, Md. : 1950) 2017; (198(7)):2699-2711 doi:10.4049/jimmunol.1601202.
PMID: 28213500 - 9
Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases.
Latour S, Fischer A
Immunological reviews 2019; (291(1)):174-189 doi:10.1111/imr.12791.
PMID: 31402499 - 10
Interleukin-2-Inducible T-Cell Kinase Deficiency-New Patients, New Insight?
Ghosh S, Drexler I, Bhatia S, et al.
Frontiers in immunology 2018; (9()):979 doi:10.3389/fimmu.2018.00979.
PMID: 29867957 - 11
High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency.
Bienemann K, Borkhardt A, Klapper W, Oschlies I
Histopathology 2015; (67(5)):607-16 doi:10.1111/his.12677.
PMID: 25728094 - 12
Atypical Clinical Course in Pediatric Hodgkin Lymphoma: Association With Germline Mutations in Interleukin-2-inducible T-Cell Kinase.
Alme C, Satwani P, Alobeid B, et al.
Journal of pediatric hematology/oncology 2015; (37(7)):507-8 doi:10.1097/MPH.0000000000000366.
PMID: 26056787 - 13
Multiple Tumors in a Patient with Interleukin-2-Inducible T-Cell Kinase Deficiency: A Case Report.
Di Filippo M, Tallone R, Muraca M, et al.
International journal of molecular sciences 2024; (25(23)) doi:10.3390/ijms252313181.
PMID: 39684891 - 14
Uncertainties experienced by parents of children diagnosed with severe combined immunodeficiency through newborn screening.
Raspa M, Kutsa O, Andrews SM, et al.
European journal of human genetics : EJHG 2024; (32(4)):392-398 doi:10.1038/s41431-023-01345-5.
PMID: 36973394 - 15
Parents' Perspectives and Societal Acceptance of Implementation of Newborn Screening for SCID in the Netherlands.
Blom M, Bredius RGM, Jansen ME, et al.
Journal of clinical immunology 2021; (41(1)):99-108 doi:10.1007/s10875-020-00886-4.
PMID: 33070266 - 16
Information and Emotional Support Needs of Families Whose Infant Was Diagnosed With SCID Through Newborn Screening.
Raspa M, Lynch M, Squiers L, et al.
Frontiers in immunology 2020; (11()):885 doi:10.3389/fimmu.2020.00885.
PMID: 32435251 - 17
Parental Engagement in Identifying Information Needs After Newborn Screening for Families of Infants with Suspected Athymia.
Howley E, Soomann M, Kreins AY
Journal of clinical immunology 2024; (44(3)):79 doi:10.1007/s10875-024-01678-w.
PMID: 38457046
This page explains your child’s ITK deficiency diagnosis for informational purposes and does not replace medical advice. Discuss genetic test results, EBV monitoring, and complication risks with your child’s immunology team.